USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sonoscape Medical Corp.

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Sonoscape ranks #43,220 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#43,220
of 49,997 US assignees by volume
Top 27%
by Innovation Score (43.7/100)
15.2
avg claims per patent
+300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R43220 · Foreign Corporation #43,220 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 6 grants
  • LOWER-Q #43,220/49,997
  • PHOTO-FINISH Solteam Incorporation
  • CPC-NARROW A61B · 5 areas
  • INNOV-PAR 43.7/100
  • CLAIMS-RICH 15.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +300% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Solteam Incorporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sonoscape’s 43.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Sonoscape

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Sonoscape's Innovation Score is 43.7/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Sonoscape?

Each dot is one of Sonoscape’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sonoscape’s own 15.2 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Sonoscape vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 510152025 Granted patents (volume) Avg claims / patent Solteam Incorporation - 6, 8.5Solteam Incorpora…Solution Seeker AS - 6, 21.17Solution Seeker ASSolvay Fluor GMBH - 6, 17.5Solvay FluorSonarmed Inc. - 6, 15.83SonarmedSonosim, Inc. - 6, 17SonosimSonuus Limited - 6, 17.33SonuusSortech AG - 6, 12.5SortechSotax Corporation - 6, 12SotaxSonoscape Medical Corp. - 6, 15.17Sonoscape Medical
Sonoscape vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sonoscape's grants concentrate

Sonoscape Medical Corp. is a focused PatentsView assignee: 5 CPC subclasses with 83.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2019. By volume, Sonoscape sits between Solteam Incorporation and Sotax Corporation.

Sonoscape's three-year grant acceleration

Sonoscape Medical Corp. shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Sonoscape's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Sonoscape holds 6 patents at rank #42,950, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Sonoscape

By rank, the assignees closest to #42,950 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Sonoscape's primary technology class.

Sonoscape's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2019202220232025 1
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Sonoscape Medical Corp. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 16.7%
2022 2 33.3%
2023 2 33.3%
2025partial year 1 16.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Sonoscape Medical Corp.'s patent record in context - here's where to go next.

  • Sonoscape Medical Corp.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 83.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #43,220 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Sonoscape Medical Corp. against Solteam Incorporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.